Explore the latest in breast cancer, including recent guidelines and advances in screening, genetic testing, and precision treatment.
This cohort study assesses 3-year clinical outcomes in patients with node-positive breast cancer who underwent targeted axillary dissection alone or in combination with axillary lymph node dissection.
This cross-sectional study analyzes health insurance coverage for lymphedema treatments from the top 3 insurance companies per state based on market share and enrollment data to determine individual access to pneumatic compression and surgical treatments across the United States.
This network meta-analysis compares expert panel and computerized evaluation modalities with patient-reported outcome measures of aesthetic outcomes after surgical treatment among patients with breast cancer.
This observational study describes the prevalence of germline genetic testing in California and Georgia between 2013 and 2019 among patients diagnosed with cancer.
This cohort study analyzes biomarker data for patients with ERBB2-positive breast cancer to determine the association between circulating cardiomyocyte cell-free DNA and subsequent cancer therapy–related cardiac dysfunction after anthracycline chemotherapy and ERBB2-targeted therapy.
This cross-sectional study examines the incidence and survival rates for Syrian adults and children with cancer residing in Turkey as refugees.
This cohort study evaluates the association of allostatic load with all-cause mortality in patients with breast cancer.
In this narrative medicine essay, a family physician writes to her deceased aunt about how their shared genetics connects their histories through which she hopes to create a future unavailable to her aunt in the 1970s.
In this narrative medicine essay, a family physician marks the moments of dread, fear, trauma, joy, and relief that began the day she was diagnosed with breast cancer to the more than 10 years of survival.
This randomized clinical trial aims to determine whether neoadjuvant de-escalated chemotherapy is superior to endocrine therapy, both in combination with pertuzumab and trastuzumab, in a highly heterogeneous hormone receptor–positive/ERBB2-positive early breast cancer.
This cohort study of women with hormone receptor–positive metastatic breast cancer treated with targeted therapy in combination with endocrine therapy compares the outcomes for those with low vs no ERBB2 expression.
This cohort study compares disparities in radiation and hormone therapy between women with breast cancer covered by Medicaid and those with private insurance using the Colorado Central Cancer Registry and data supplemented with All Payer Claims Data.
This cohort study investigates whether adherence to overlapping cancer prevention lifestyle recommendations before, during, and after treatment was associated with recurrence or mortality among patients with high-risk breast cancer.
This randomized clinical trial determines the efficacy of bacterial decolonization to reduce the severity of acute radiation dermatitis compared with standard of care.
This cohort study assesses the association of Staphylococcus aureus colonization with acute dermatitis severity in patients with breast or head and neck cancer.
This case series investigates the association between time from breast cancer diagnosis to primary breast surgery and overall patient survival.
This randomized clinical trial of patients in the Netherlands who have undergone mastectomy compares self-reported quality of life among those receiving total breast reconstruction using autologous fat transfer with that among those receiving implant-based reconstruction.
Customize your JAMA Network experience by selecting one or more topics from the list below.